Immunovant GAAP EPS of -$0.61 beats by $0.10 [Seeking Alpha]
Immunovant, Inc. (IMVT)
Company Research
Source: Seeking Alpha
As of December 31, 2025, Immunovant's cash and cash equivalents totaled $994.5 million, providing runway for announced indications through the potential commercial launch of IMVT-1402 in GD. More on Immunovant Immunovant: 'Buy' On Competitive Batoclimab Landscape And IMVT-1402 Advancement Immunovant, Inc. (IMVT) Q2 2025 Earnings Call Transcript Immunovant drops 7%, prices $550M stock offering Seeking Alpha's Quant Rating on Immunovant Historical earnings data for Immunovant Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
IMVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMVT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMVT alerts
High impacting Immunovant, Inc. news events
Weekly update
A roundup of the hottest topics
IMVT
News
- Immunovant Q3 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025GlobeNewswire
- Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026GlobeNewswire
- Immunovant (NASDAQ:IMVT) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Truist Lifts Immunovant (IMVT) PT to $22 on Updated 2026 Financial Modeling [Yahoo! Finance]Yahoo! Finance
IMVT
Earnings
- 2/6/26 - Beat
IMVT
Sec Filings
- 2/6/26 - Form 10-Q
- 2/6/26 - Form 8-K
- 1/23/26 - Form 4
- IMVT's page on the SEC website